Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Annals of Hematology|January 27, 2022
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrationsSayantanee Dutta, Jennifer Moritz, Gudrun Pregartner, et al.
American Journal of Hematology|July 1, 2020
Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profilingShruti Daga, Angelika Rosenberger, Karl Kashofer, et al.
Blood|November 16, 2014
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibitionSubarna Sinha, Daniel Thomas, Linda Yu, et al.
Nature Communications|June 1, 2017
Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor dataSubarna Sinha, Daniel Thomas, Steven Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2024
Performance of Diagnostic Algorithms in Patients With Invasive Pulmonary AspergillosisStefan Hatzl, Christina Geiger, Lisa Kriegl, et al.
Leukemia|February 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilitiesJohannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, et al.
Wiener Klinische Wochenschrift|November 11, 2024
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care centerSonja Wurm, Michael Waltersdorfer, Simone Loindl, et al.
Critical Care Explorations|March 21, 2024
Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot StudyLaura Scholz, Florian Posch, Eduard Schulz, et al.
EMBO Reports|February 14, 2022
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibodyDenis Tvorogov, Chloe A L Thompson-Peach, Johannes Foßelteder, et al.
Cancer Discovery|November 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal VulnerabilityDaniel Thomas, Manhong Wu, Yusuke Nakauchi, et al.
Pageof 7